ARGS - Argos Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.85M
Enterprise Value 313.28M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.98
Price/Book (mrq)N/A
Enterprise Value/Revenue 36.99
Enterprise Value/EBITDA 6-0.43

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-1,681.58%

Management Effectiveness

Return on Assets (ttm)-33.84%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.9M
Revenue Per Share (ttm)0.63
Quarterly Revenue Growth (yoy)921.10%
Gross Profit (ttm)1.9M
EBITDA -30.97M
Net Income Avi to Common (ttm)-40.58M
Diluted EPS (ttm)-23.699
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.19M
Total Cash Per Share (mrq)1.92
Total Debt (mrq)19.46M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.80
Book Value Per Share (mrq)-4.31

Cash Flow Statement

Operating Cash Flow (ttm)-35.42M
Levered Free Cash Flow (ttm)-30.86M

Trading Information

Stock Price History

Beta 0.98
52-Week Change 3-98.05%
S&P500 52-Week Change 313.32%
52 Week High 311.140
52 Week Low 30.000
50-Day Moving Average 30.477
200-Day Moving Average 31.945

Share Statistics

Avg Vol (3 month) 3684.91k
Avg Vol (10 day) 369.35k
Shares Outstanding 510.59M
Float 6.38M
% Held by Insiders 126.09%
% Held by Institutions 16.56%
Shares Short 37.36M
Short Ratio 31.1
Short % of Float 337.42%
Shares Short (prior month) 35.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/20
Last Split Date 3Jan 19, 2018